- Home
- MDGL vs KD Comparison
MDGL vs KD Comparison
Compare MDGL & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- KD
- Stock Information
- Founded
- MDGL 2011
- KD 2020
- Country
- MDGL United States
- KD United States
- Employees
- MDGL N/A
- KD N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- KD EDP Services
- Sector
- MDGL Health Care
- KD Technology
- Exchange
- MDGL Nasdaq
- KD Nasdaq
- Market Cap
- MDGL 6.8B
- KD 6.8B
- IPO Year
- MDGL N/A
- KD N/A
- Fundamental
- Price
- MDGL $282.86
- KD $41.20
- Analyst Decision
- MDGL Strong Buy
- KD Strong Buy
- Analyst Count
- MDGL 10
- KD 3
- Target Price
- MDGL $420.63
- KD $43.33
- AVG Volume (30 Days)
- MDGL 382.7K
- KD 2.0M
- Earning Date
- MDGL 05-01-2025
- KD 05-07-2025
- Dividend Yield
- MDGL N/A
- KD N/A
- EPS Growth
- MDGL N/A
- KD N/A
- EPS
- MDGL N/A
- KD 1.05
- Revenue
- MDGL $317,383,000.00
- KD $15,057,000,000.00
- Revenue This Year
- MDGL $264.55
- KD $3.61
- Revenue Next Year
- MDGL $67.21
- KD $2.77
- P/E Ratio
- MDGL N/A
- KD $39.25
- Revenue Growth
- MDGL N/A
- KD N/A
- 52 Week Low
- MDGL $200.08
- KD $21.34
- 52 Week High
- MDGL $377.46
- KD $43.61
- Technical
- Relative Strength Index (RSI)
- MDGL 35.76
- KD 79.33
- Support Level
- MDGL $287.46
- KD $32.66
- Resistance Level
- MDGL $307.54
- KD $33.79
- Average True Range (ATR)
- MDGL 16.58
- KD 1.15
- MACD
- MDGL -2.70
- KD 1.12
- Stochastic Oscillator
- MDGL 3.19
- KD 96.36
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.